Literature DB >> 20978557

Concomitant therapy of Crohn's disease and hepatitis C with budesonide and antivirals.

Alok Gupta1, Michael D Sitrin.   

Abstract

Entities:  

Year:  2010        PMID： 20978557      PMCID： PMC2950670     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  13 in total

1.  Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.

Authors:  Manal F Abdelmalek; Chen Liu; John F Valentine
Journal:  Am J Gastroenterol       Date:  2007-06       Impact factor: 10.864

2.  Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection.

Authors:  B Kallinowski; K Haseroth; G Marinos; C Hanck; W Stremmel; L Theilmann; M V Singer; S Rossol
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Onset of inflammatory bowel diseases during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases.

Authors:  Federica Villa; Maria Grazia Rumi; Clementina Signorelli; Simone Saibeni; Ersilio Del Ninno; Stefano Ferrero Bogetto; Roberto de Franchis; Maurizio Vecchi
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 2.566

4.  Hepatitis B and C virus infection in Crohn's disease.

Authors:  L Biancone; M Pavia; G Del Vecchio Blanco; R D'Incà; F Castiglione; F De Nigris; P Doldo; F Cosco; P Vavassori; G P Bresci; A Arrigoni; G Cadau; I Monteleone; A Rispo; W Fries; B Mallardi; G C Sturniolo; F Pallone
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

5.  Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein.

Authors:  R B Ray; K Meyer; R Steele; A Shrivastava; B B Aggarwal; R Ray
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  Onset of coeliac disease during treatment with interferon for chronic hepatitis C.

Authors:  G Cammarota; L Cuoco; R Cianci; F Pandolfi; G Gasbarrini
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

7.  Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  T L Fong; B Valinluck; S Govindarajan; F Charboneau; R H Adkins; A G Redeker
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

8.  A comparison of budesonide with prednisolone for active Crohn's disease.

Authors:  P Rutgeerts; R Löfberg; H Malchow; C Lamers; G Olaison; D Jewell; A Danielsson; H Goebell; O O Thomsen; H Lorenz-Meyer
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

Review 9.  Budesonide for maintenance of remission in Crohn's disease.

Authors:  Eric I Benchimol; Cynthia H Seow; Anthony R Otley; A Hillary Steinhart
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases.

Authors:  S Aslanidis; T Vassiliadis; A Pyrpasopoulou; I Douloumpakas; C Zamboulis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 3.650
View more
  2 in total

1.  Treatment of chronic hepatitis C in patients with Crohn's disease.

Authors:  Jill Gaidos; Virginia Clark; John F Valentine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

Review 2.  Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.

Authors:  Kohtaro Ooka; Joseph K Lim
Journal:  J Clin Transl Hepatol       Date:  2016-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.